ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2401

Mucocutaneous Lesions and Recurrent Fevers in Patients with Trisomy 8 Mosaicism and Chromosome 8 Duplication

Kalpana Manthiram1, Sandro Perazzio2, Deborah Bruns3, Ivona Aksentijevich4, Troy R. Torgerson5 and Daniel L. Kastner4, 1National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 2Rheumatology, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, WA, 3Southern Illinois University Carbondale, Carbondale, IL, 4Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 5Pediatric Immunology/Rheumatology, University of Washington School of Medicine & Seattle Children's Research Institute, Seattle, WA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoinflammation, fever and ulcers

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Many patients with myelodysplastic syndromes with somatic trisomy 8 in the bone marrow and Behcet’s-like ulcerations have been described. A handful of patients with constitutional trisomy 8 mosaicism with Behcet’s-like disease have been reported but the spectrum of phenotypes has not been characterized in detail.

Methods: Patients with trisomy 8 mosaicism and chromosome 8 duplications who contacted the NIH Autoinflammatory Clinic were interviewed by phone regarding symptoms of recurrent fever, mucosal lesions, and rashes.

Results: A total of 52 patients were interviewed of whom 19 (37%) had trisomy 8 mosaicism and 33 (63%) had chromosome 8 duplications. The average age of patients was 13 years (range 13 months to 40 years). Thirty-eight percent reported a history of 4 or more fever episodes in one year. The average age of episode onset was 23 months; episodes on average lasted 3.7 days with 6 week intervals. During episodes, 65% reported pharyngitis or sore throat, 45% oral ulcers, 45% rash, 35% cervical lymphadenopathy, 35% headache, and 35% abdominal pain. Twenty-five (48%) reported a history of mucosal ulcers of which 84% were oral, 20% were esophageal, 8% were gastric, 8% were colonic, and 20% were genital. Eleven patients (21%) reported having large (>1cm), painful, oral ulcers that took over a week to resolve. Eleven patients (21%) reported recurrent, painful papular or ulcerative rashes. Two patients reported rapid resolution of fever flares with 1 dose of corticosteroid, while two others required longer steroid courses. One patient had episode remission while on colchicine while another had transient improvement on colchicine. Two patients underwent tonsillectomy with no effect. One patient with severe ulcers underwent bone marrow transplant with significant improvement in ulcerative disease.

Conclusion: Patients with trisomy 8 mosaicism and chromosome 8 duplications have a propensity for systemic inflammatory disease that is similar to Behcet’s disease in some patients and similar to periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in others. This could be due to duplication and subsequent overexpression of particular genes on chromosome 8 that regulate inflammatory responses. We are currently genotyping affected patients using high-density SNP arrays to identify a possible minimal duplicated region in common to these patients. We are collecting blood samples and biopsies from ulcers and rashes from these patients for future studies.


Disclosure: K. Manthiram, None; S. Perazzio, None; D. Bruns, None; I. Aksentijevich, None; T. R. Torgerson, None; D. L. Kastner, None.

To cite this abstract in AMA style:

Manthiram K, Perazzio S, Bruns D, Aksentijevich I, Torgerson TR, Kastner DL. Mucocutaneous Lesions and Recurrent Fevers in Patients with Trisomy 8 Mosaicism and Chromosome 8 Duplication [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/mucocutaneous-lesions-and-recurrent-fevers-in-patients-with-trisomy-8-mosaicism-and-chromosome-8-duplication/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mucocutaneous-lesions-and-recurrent-fevers-in-patients-with-trisomy-8-mosaicism-and-chromosome-8-duplication/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology